Hospital of Barstow INC
Hospital of Barstow INC was paid $16.88M by Medicaid between Jan 2018 and Dec 2024, across 199 billing codes. Its largest line is 0450, Emergency room services — 18% of everything it billed.
BARSTOW, CA 92311
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 82,445 | $2.22M | |
| 2019 | 90,168 | $2.32M | |
| 2020 | 64,851 | $1.80M | |
| 2021 | 69,208 | $2.01M | |
| 2022 | 97,487 | $2.81M | |
| 2023 | 100,941 | $2.94M | |
| 2024incomplete | 96,962 | $2.77M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 18% | 45,618 | 37,891 | $3.07M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 37,101 | 32,061 | $2.07M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 4,870 | 4,692 | $757K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 11,368 | 10,458 | $704K |
| Z7502 | 4.1% | 19,174 | 18,604 | $700K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.6% | 2,863 | 2,784 | $608K |
| 80053 | Comprehensive metabolic panel | 3.1% | 32,460 | 29,254 | $532K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 13,251 | 12,251 | $414K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.3% | 9,173 | 8,400 | $394K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.3% | 3,548 | 3,434 | $383K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.2% | 3,591 | 3,330 | $376K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 34,068 | 30,510 | $360K |
187 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 4,622 | $349K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.0% | 11,392 | $335K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 9,355 | $320K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 5,626 | $289K |
| 99070 | 1.7% | 48,463 | $282K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.7% | 1,369 | $279K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 6,006 | $237K |
| 99285 | Emergency room visit (most serious) | 1.4% | 2,836 | $235K |
| Z7610 | 1.1% | 14,252 | $194K | |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 7,457 | $188K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.1% | 2,037 | $179K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,723 | $167K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,472 | $126K |
| 84484 | <1% | 8,538 | $120K | |
| 87634 | <1% | 1,785 | $115K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,070 | $106K |
| 80306 | <1% | 6,612 | $103K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,608 | $102K |
| 87400 | <1% | 16,008 | $91K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 830 | $91K |
| 83690 | <1% | 8,915 | $89K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,382 | $89K |
| 99499 | <1% | 1,729 | $82K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,674 | $79K |
| 81025 | <1% | 9,714 | $78K | |
| 83880 | <1% | 3,577 | $78K | |
| 59025 | Fetal non-stress test | <1% | 3,614 | $76K |
| 81001 | <1% | 14,179 | $70K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,211 | $69K |
| J3490 | Unclassified drugs | <1% | 19,837 | $67K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,068 | $66K |
| 87040 | <1% | 3,641 | $66K | |
| 87430 | <1% | 3,917 | $61K | |
| 87070 | <1% | 3,697 | $54K | |
| 84702 | <1% | 2,474 | $50K | |
| 81003 | <1% | 15,057 | $49K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,839 | $48K |
| 72131 | <1% | 251 | $45K | |
| 84703 | <1% | 3,937 | $44K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,958 | $43K |
| 87186 | <1% | 2,992 | $43K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,451 | $42K |
| 0761 | <1% | 1,155 | $41K | |
| 73630 | <1% | 1,493 | $41K | |
| 70486 | <1% | 239 | $41K | |
| 99221 | <1% | 253 | $40K | |
| 93971 | <1% | 405 | $40K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 423 | $40K |
| 82962 | <1% | 7,070 | $39K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,064 | $39K |
| 73130 | <1% | 1,359 | $37K | |
| 83605 | <1% | 2,280 | $36K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 668 | $35K |
| 90715 | <1% | 938 | $33K | |
| 73610 | <1% | 1,177 | $33K | |
| 73030 | <1% | 1,195 | $33K | |
| 73562 | <1% | 1,168 | $30K | |
| 74018 | <1% | 1,564 | $29K | |
| 71250 | <1% | 180 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,340 | $24K |
| 74022 | <1% | 534 | $23K | |
| 85670 | <1% | 3,068 | $23K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,081 | $22K |
| 73110 | <1% | 747 | $21K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 881 | $21K |
| 85610 | <1% | 3,343 | $18K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,459 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,460 | $16K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 277 | $16K |
| 76830 | Ultrasound, transvaginal | <1% | 223 | $16K |
| 82805 | <1% | 377 | $15K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,661 | $15K |
| 72100 | <1% | 507 | $14K | |
| 76801 | <1% | 242 | $14K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 83 | $13K |
| 86850 | <1% | 1,055 | $13K | |
| 87077 | <1% | 1,866 | $12K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 178 | $11K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 820 | $11K |
| 0250 | <1% | 4,388 | $11K | |
| 86756 | <1% | 462 | $10K | |
| 0710 | <1% | 225 | $10K | |
| 86901 | <1% | 1,501 | $10K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,279 | $9K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,480 | $9K |
| 0360 | <1% | 69 | $8K | |
| 86900 | <1% | 1,858 | $8K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,466 | $8K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 124 | $8K |
| 85380 | <1% | 1,642 | $8K | |
| 76775 | <1% | 146 | $7K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 264 | $7K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,083 | $7K |
| 83735 | <1% | 848 | $7K | |
| 51702 | <1% | 82 | $7K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 985 | $7K |
| 87210 | <1% | 992 | $7K | |
| 93970 | <1% | 38 | $7K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,343 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,908 | $6K |
| 82550 | <1% | 620 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 71 | $5K |
| Z7500 | <1% | 136 | $5K | |
| 85027 | <1% | 499 | $4K | |
| 99218 | <1% | 26 | $4K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 13 | $3K |
| 86403 | <1% | 181 | $3K | |
| 82150 | <1% | 328 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 223 | $3K |
| 73080 | <1% | 96 | $3K | |
| 92588 | <1% | 54 | $2K | |
| 0270 | <1% | 269 | $2K | |
| 96367 | <1% | 51 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $2K |
| 73140 | <1% | 105 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 553 | $2K |
| 82010 | <1% | 161 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $2K |
| 73090 | <1% | 60 | $2K | |
| 29125 | <1% | 82 | $2K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 270 | $2K |
| 29515 | <1% | 86 | $2K | |
| 76641 | <1% | 24 | $2K | |
| 86922 | <1% | 12 | $2K | |
| 12001 | <1% | 86 | $2K | |
| 0258 | <1% | 544 | $2K | |
| 82274 | <1% | 37 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,134 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 25 | $1K |
| 73590 | <1% | 67 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 26 | $1K |
| 99217 | <1% | 47 | $1K | |
| 96376 | <1% | 72 | $1K | |
| V5008 | Hearing screening | <1% | 30 | $1K |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 211 | $1K |
| 0370 | <1% | 19 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,588 | $1K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 421 | $1K |
| 85007 | <1% | 266 | $1K | |
| 86592 | <1% | 164 | $1K | |
| 82553 | <1% | 64 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 330 | $1K |
| 83874 | <1% | 47 | $887.23 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 925 | $844.01 |
| 86920 | <1% | 12 | $801.71 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 653 | $801.71 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 136 | $787.17 |
| 86140 | <1% | 113 | $786.43 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 199 | $728.30 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 38 | $642.93 |
| J1815 | Injection, insulin, per 5 units | <1% | 56 | $630.27 |
| 84100 | <1% | 115 | $545.80 | |
| 71101 | <1% | 14 | $538.53 | |
| 71020 | <1% | 24 | $510.93 | |
| 73502 | <1% | 19 | $498.40 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 68 | $488.37 |
| 76536 | <1% | 12 | $452.40 | |
| 73600 | <1% | 24 | $429.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 93 | $427.09 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 171 | $423.74 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 268 | $397.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 89 | $358.36 |
| 72040 | <1% | 13 | $274.60 | |
| 80061 | Lipid panel | <1% | 16 | $239.09 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 268 | $236.55 |
| 87081 | <1% | 30 | $205.43 | |
| 82140 | <1% | 16 | $191.80 | |
| 94761 | <1% | 18 | $175.78 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 45 | $173.54 |
| 86702 | <1% | 12 | $169.76 | |
| 12002 | <1% | 13 | $158.40 | |
| 85651 | <1% | 27 | $126.86 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 13 | $103.50 |
| 36600 | <1% | 28 | $84.15 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 227 | $75.40 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 74 | $74.06 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 13 | $40.96 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 96 | $37.80 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 70 | $27.20 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 70 | $21.20 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 13 | $14.72 |
| 0255 | <1% | 12 | $14.43 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 14 | $12.65 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 45 | $9.07 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 19 | $0.38 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 434 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Jackson Hospital Corporation | Jackson, KY | $34.90M |
| Deming Hospital Corporation | Deming, NM | $34.61M |
| Hospital of Louisa, INC. | Louisa, KY | $27.77M |
| Paintsville Hospital Company, LLC | Paintsville, KY | $15.46M |
| San Miguel Hospital Corporation | Las Vegas, NM | $13.21M |
| Tooele Hospital Corporation | Tooele, UT | $11.66M |
| Forrest City Arkansas Hospital Company LLC | Forrest City, AR | $7.42M |
| MMC of Nevada LLC | Mesquite, NV | $2.60M |
| Fort Payne Hospital Corporation | Fort Payne, AL | $2.60M |
| Williamston Hospital Corporation | Williamston, NC | $2.31M |
| Waukegan Illinois Hospital Company LLC | Waukegan, IL | $2.30M |
| Southwest Kidney Institute Vascular Center LLC | Tempe, AZ | $850K |
| Evanston Hospital Corporation | Evanston, WY | $378K |
| Marion Hospital Corporation | Marion, IL | $220K |
| Anna Hospital Corporation | Anna, IL | $217K |
| National Healthcare of MT Vernon INC | Mount Vernon, IL | $158K |
| Red Bud Illinois Hospital Company LLC | Red Bud, IL | $36K |
| Tooele Hospital Corporation | Tooele, UT | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.